This website is intended for healthcare professionals only.
Newsletter
MENU
MENU
News
Covid-19
Clinical
Allergy
Emergency and critical care
Gastroenterology
Respiratory
Cardiovascular
Oncology/Haematology
Radiology and Imaging
Rheumatology
Educational resources
Issues
2021
2020
2019
2018
2017
2016
Sponsored
MENU
MENU
News
Covid-19
Clinical
Allergy
Emergency and critical care
Gastroenterology
Respiratory
Cardiovascular
Oncology/Haematology
Radiology and Imaging
Rheumatology
Educational resources
Issues
2021
2020
2019
2018
2017
2016
Sponsored
Clinical
Test can personalise use of immunotherapy and chemotherapy for head and neck cancer
Real-world analysis reveals high level of recurrent cardiovascular events and death 6 months after primary episode
Cardiac biomarkers offer no benefit to CV risk stratification in psoriasis disease
Trial shows that cocoa extract reduces death rate but not overall cardiovascular events
Prospective analysis shows regular meat eaters at higher risk of several types of cancer
Replacing sugar-containing drinks with no-calorie sweeteners reduces cardiometabolic risk
Seroconversion rates low after COVID-19 vaccination among immunocompromised
Psoriasis patients self-report higher analgesic usage largely due to joint pain
DOACs superior to prophylactic doses of heparins for thromboprophylaxis in non-cardiac surgery
Mortality benefit from higher daily steps plateaus
Empagliflozin effective for patients hospitalised with acute heart failure
Breast density associated with family history of breast cancer in premenopausal women
Page 4 of 151
« First
«
...
2
3
4
5
6
...
10
20
30
...
»
Last »
Popular articles
Alirocumab and statin therapy leads to plaque regression in acute MI
18 May, 2022
Analysis of the Tromsø study shows that espresso coffee increases total serum cholesterol levels
19 May, 2022
ENO Breathe programme for long COVID improves mental wellbeing and some aspects of breathlessness
19 May, 2022
Elevated arterial stiffness best predictor of diabetes in hypertensive patients
20 May, 2022
Meta-analysis finds PCSK9 inhibitors and ezetimibe combined with statins reduce non-fatal MI and stroke in high risk patients but not death
20 May, 2022